과제정보
This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT) (No. 2018R1A2B6003143).
참고문헌
- Vlak MH, Algra A, Brandenburg R, Rinkel GJ. Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: a systematic review and meta-analysis. Lancet Neurol 2011;10:626-636 https://doi.org/10.1016/S1474-4422(11)70109-0
- Ronkainen A, Hernesniemi J, Puranen M, Niemitukia L, Vanninen R, Ryynanen M, et al. Familial intracranial aneurysms. Lancet 1997;349:380-384 https://doi.org/10.1016/S0140-6736(97)80009-8
- Broderick JP, Brown RD Jr, Sauerbeck L, Hornung R, Huston J 3rd, Woo D, et al. Greater rupture risk for familial as compared to sporadic unruptured intracranial aneurysms. Stroke 2009;40:1952-1957 https://doi.org/10.1161/STROKEAHA.108.542571
- Brown RD Jr, Broderick JP. Unruptured intracranial aneurysms: epidemiology, natural history, management options, and familial screening. Lancet Neurol 2014;13:393-404 https://doi.org/10.1016/S1474-4422(14)70015-8
- Rinkel GJ, Djibuti M, Algra A, van Gijn J. Prevalence and risk of rupture of intracranial aneurysms: a systematic review. Stroke 1998;29:251-256 https://doi.org/10.1161/01.STR.29.1.251
- Hitchcock E, Gibson WT. A review of the genetics of intracranial berry aneurysms and implications for genetic counseling. J Genet Couns 2017;26:21-31 https://doi.org/10.1007/s10897-016-0029-8
- Zhou S, Dion PA, Rouleau GA. Genetics of intracranial aneurysms. Stroke 2018;49:780-787 https://doi.org/10.1161/STROKEAHA.117.018152
- Sauvigny T, Alawi M, Krause L, Renner S, Spohn M, Busch A, et al. Exome sequencing in 38 patients with intracranial aneurysms and subarachnoid hemorrhage. J Neurol 2020;267:2533-2545 https://doi.org/10.1007/s00415-020-09865-6
- Vaser R, Adusumalli S, Leng SN, Sikic M, Ng PC. SIFT missense predictions for genomes. Nat Protoc 2016;11:1-9 https://doi.org/10.1038/nprot.2015.123
- Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, et al. A method and server for predicting damaging missense mutations. Nat Methods 2010;7:248-249 https://doi.org/10.1038/nmeth0410-248
- Davydov EV, Goode DL, Sirota M, Cooper GM, Sidow A, Batzoglou S. Identifying a high fraction of the human genome to be under selective constraint using GERP++. PLoS Comput Biol 2010;6:e1001025
- Kircher M, Witten DM, Jain P, O'Roak BJ, Cooper GM, Shendure J. A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet 2014;46:310-315 https://doi.org/10.1038/ng.2892
- Ioannidis NM, Rothstein JH, Pejaver V, Middha S, McDonnell SK, Baheti S, et al. REVEL: an ensemble method for predicting the pathogenicity of rare missense variants. Am J Hum Genet 2016;99:877-885 https://doi.org/10.1016/j.ajhg.2016.08.016
- Jagadeesh KA, Wenger AM, Berger MJ, Guturu H, Stenson PD, Cooper DN, et al. M-CAP eliminates a majority of variants of uncertain significance in clinical exomes at high sensitivity. Nat Genet 2016;48:1581-1586 https://doi.org/10.1038/ng.3703
- Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature 2016;536:285-291 https://doi.org/10.1038/nature19057
- Huang N, Lee I, Marcotte EM, Hurles ME. Characterising and predicting haploinsufficiency in the human genome. PLoS Genet 2010;6:e1001154
- Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015;17:405-423 https://doi.org/10.1038/gim.2015.30
- Rehm HL, Bale SJ, Bayrak-Toydemir P, Berg JS, Brown KK, Deignan JL, et al. ACMG clinical laboratory standards for next-generation sequencing. Genet Med 2013;15:733-747 https://doi.org/10.1038/gim.2013.92
- Riggs ER, Andersen EF, Cherry AM, Kantarci S, Kearney H, Patel A, et al. Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen). Genet Med 2020;22:245-257 https://doi.org/10.1038/s41436-019-0686-8
- Bourcier R, Le Scouarnec S, Bonnaud S, Karakachoff M, Bourcereau E, Heurtebise-Chretien S, et al. Rare coding variants in ANGPTL6 are associated with familial forms of intracranial aneurysm. Am J Hum Genet 2018;102:133-141 https://doi.org/10.1016/j.ajhg.2017.12.006
- Ding X, Zhao S, Zhang Q, Yan Z, Wang Y, Wu Y, et al. Exome sequencing reveals a novel variant in NFX1 causing intracranial aneurysm in a Chinese family. J Neurointerv Surg 2020;12:221-226 https://doi.org/10.1136/neurintsurg-2019-014900
- Powell AE, Fernandez BA, Maroun F, Noble B, Woods MO. Familial intracranial aneurysm in newfoundland: clinical and genetic analysis. Can J Neurol Sci 2019;46:518-526 https://doi.org/10.1017/cjn.2019.230
- Santiago-Sim T, Fang X, Hennessy ML, Nalbach SV, DePalma SR, Lee MS, et al. THSD1 (thrombospondin type 1 domain containing protein 1) mutation in the pathogenesis of intracranial aneurysm and subarachnoid hemorrhage. Stroke 2016;47:3005-3013 https://doi.org/10.1161/STROKEAHA.116.014161
- Wu Y, Li Z, Shi Y, Chen L, Tan H, Wang Z, et al. Exome sequencing identifies LOXL2 mutation as a cause of familial intracranial aneurysm. World Neurosurg 2018;109:e812-e818 https://doi.org/10.1016/j.wneu.2017.10.094
- Yan J, Hitomi T, Takenaka K, Kato M, Kobayashi H, Okuda H, et al. Genetic study of intracranial aneurysms. Stroke 2015;46:620-626 https://doi.org/10.1161/STROKEAHA.114.007286
- Yang X, Li J, Fang Y, Zhang Z, Jin D, Chen X, et al. Rho guanine nucleotide exchange factor ARHGEF17 is a risk gene for intracranial aneurysms. Circ Genom Precis Med 2018;11:e002099
- Zhou S, Ambalavanan A, Rochefort D, Xie P, Bourassa CV, Hince P, et al. RNF213 is associated with intracranial aneurysms in the French-Canadian population. Am J Hum Genet 2016;99:1072-1085 https://doi.org/10.1016/j.ajhg.2016.09.001
- Hong EP, Kim BJ, Cho SS, Yang JS, Choi HJ, Kang SH, et al. Genomic variations in susceptibility to intracranial aneurysm in the Korean population. J Clin Med 2019;8:275
- Luukkonen TM, Poyhonen M, Palotie A, Ellonen P, Lagstrom S, Lee JH, et al. A balanced translocation truncates Neurotrimin in a family with intracranial and thoracic aortic aneurysm. J Med Genet 2012;49:621-629 https://doi.org/10.1136/jmedgenet-2012-100977
- Naunheim MR, Walcott BP, Nahed BV, MacRae CA, Levinson JR, Ogilvy CS. Arterial tortuosity syndrome with multiple intracranial aneurysms: a case report. Arch Neurol 2011;68:369-371 https://doi.org/10.1001/archneurol.2011.29
- D'hondt S, Van Damme T, Malfait F. Vascular phenotypes in nonvascular subtypes of the Ehlers-Danlos syndrome: a systematic review. Genet Med 2018;20:562-573 https://doi.org/10.1038/gim.2017.138
- Myllyharju J, Kivirikko KI. Collagens and collagen-related diseases. Ann Med 2001;33:7-21 https://doi.org/10.3109/07853890109002055
- Ruotsalainen H, Sipila L, Vapola M, Sormunen R, Salo AM, Uitto L, et al. Glycosylation catalyzed by lysyl hydroxylase 3 is essential for basement membranes. J Cell Sci 2006;119:625-635 https://doi.org/10.1242/jcs.02780
- Ewans LJ, Colley A, Gaston-Massuet C, Gualtieri A, Cowley MJ, McCabe MJ, et al. Pathogenic variants in PLOD3 result in a Stickler syndrome-like connective tissue disorder with vascular complications. J Med Genet 2019;56:629-638 https://doi.org/10.1136/jmedgenet-2019-106019
- Salo AM, Cox H, Farndon P, Moss C, Grindulis H, Risteli M, et al. A connective tissue disorder caused by mutations of the lysyl hydroxylase 3 gene. Am J Hum Genet 2008;83:495-503 https://doi.org/10.1016/j.ajhg.2008.09.004
- Vahidnezhad H, Youssefian L, Saeidian AH, Touati A, Pajouhanfar S, Baghdadi T, et al. Mutations in PLOD3, encoding lysyl hydroxylase 3, cause a complex connective tissue disorder including recessive dystrophic epidermolysis bullosa-like blistering phenotype with abnormal anchoring fibrils and type VII collagen deficiency. Matrix Biol 2019;81:91-106 https://doi.org/10.1016/j.matbio.2018.11.006
- Sellar GC, Watt KP, Rabiasz GJ, Stronach EA, Li L, Miller EP, et al. OPCML at 11q25 is epigenetically inactivated and has tumor-suppressor function in epithelial ovarian cancer. Nat Genet 2003;34:337-343 https://doi.org/10.1038/ng1183
- Worrall BB, Foroud T, Brown RD Jr, Connolly ES, Hornung RW, Huston J 3rd, et al. Genome screen to detect linkage to common susceptibility genes for intracranial and aortic aneurysms. Stroke 2009;40:71-76 https://doi.org/10.1161/STROKEAHA.108.522631
- Ozturk AK, Nahed BV, Bydon M, Bilguvar K, Goksu E, Bademci G, et al. Molecular genetic analysis of two large kindreds with intracranial aneurysms demonstrates linkage to 11q24-25 and 14q23-31. Stroke 2006;37:1021-1027 https://doi.org/10.1161/01.STR.0000206153.92675.b9
- Hirose T, Mizumoto S, Hashimoto A, Takahashi Y, Yoshizawa T, Nitahara-Kasahara Y, et al. Systematic investigation of the skin in Chst14-/- mice: a model for skin fragility in musculocontractural Ehlers-Danlos syndrome caused by CHST14 variants (mcEDS-CHST14). Glycobiology 2020;31:137-150 https://doi.org/10.1093/glycob/cwaa058
- Kosho T, Mizumoto S, Watanabe T, Yoshizawa T, Miyake N, Yamada S. Recent advances in the pathophysiology of musculocontractural Ehlers-Danlos syndrome. Genes (Basel) 2019;11:43
- Balestrino R, Tunesi S, Tesei S, Lopiano L, Zecchinelli AL, Goldwurm S. Penetrance of glucocerebrosidase (GBA) mutations in Parkinson's disease: a kin cohort study. Mov Disord 2020;35:2111-2114 https://doi.org/10.1002/mds.28200
- Pastores GM, Hughes DA. Gaucher disease. Ncbi.nlm.nih.gov Web site. https://www.ncbi.nlm.nih.gov/books/NBK1269/. Accessed June 11th, 2021
- Coucke PJ, Willaert A, Wessels MW, Callewaert B, Zoppi N, De Backer J, et al. Mutations in the facilitative glucose transporter GLUT10 alter angiogenesis and cause arterial tortuosity syndrome. Nat Genet 2006;38:452-457 https://doi.org/10.1038/ng1764
- Callewaert BL, Willaert A, Kerstjens-Frederikse WS, De Backer J, Devriendt K, Albrecht B, et al. Arterial tortuosity syndrome: clinical and molecular findings in 12 newly identified families. Hum Mutat 2008;29:150-158 https://doi.org/10.1002/humu.20623
- Kim CJ, Park SS, Lee HS, Chung HJ, Choi W, Chung JH, et al. Identification of an autosomal dominant locus for intracranial aneurysm through a model-based family collection in a geographically limited area. J Hum Genet 2011;56:464-466 https://doi.org/10.1038/jhg.2011.27
- Priori SG, Napolitano C, Tiso N, Memmi M, Vignati G, Bloise R, et al. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation 2001;103:196-200 https://doi.org/10.1161/01.CIR.103.2.196
- Malek N, Weil RS, Bresner C, Lawton MA, Grosset KA, Tan M, et al. Features of GBA-associated Parkinson's disease at presentation in the UK Tracking Parkinson's study. J Neurol Neurosurg Psychiatry 2018;89:702-709 https://doi.org/10.1136/jnnp-2017-317348